A2 BIOTHERAPEUTICS Trademark

Trademark Overview

On Thursday, February 14, 2019, a trademark application was filed for A2 BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the A2 BIOTHERAPEUTICS trademark a serial number of 88302588. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by A2 Biotherapeutics, Inc.. The A2 BIOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer
a2 biotherapeutics

General Information

Serial Number88302588
Word MarkA2 BIOTHERAPEUTICS
Filing DateThursday, February 14, 2019
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7026075
Registration DateTuesday, April 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Pseudo MarkA TWO BIO THERAPEUTICS
Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Goods and Servicesidentification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2019
Primary Code042
First Use Anywhere DateThursday, December 31, 2020
First Use In Commerce DateThursday, December 31, 2020

Trademark Owner History

Party NameA2 Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301
Party NameA2 Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301
Party NameA2 Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAgoura Hills, CA 91301

Trademark Events

Event DateEvent Description
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 13, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 9, 2023USE AMENDMENT FILED
Thursday, February 9, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 5 GRANTED
Thursday, July 28, 2022SOU EXTENSION 5 FILED
Tuesday, August 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 28, 2022TEAS EXTENSION RECEIVED
Wednesday, July 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 4 GRANTED
Friday, February 4, 2022SOU EXTENSION 4 FILED
Friday, February 4, 2022TEAS EXTENSION RECEIVED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 15, 2021SOU EXTENSION 3 GRANTED
Thursday, July 15, 2021SOU EXTENSION 3 FILED
Thursday, July 15, 2021TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 2, 2021SOU EXTENSION 2 GRANTED
Tuesday, February 2, 2021SOU EXTENSION 2 FILED
Tuesday, February 2, 2021TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020SOU EXTENSION 1 GRANTED
Monday, July 20, 2020SOU EXTENSION 1 FILED
Monday, July 20, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2019ASSIGNED TO LIE
Tuesday, November 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2019NON-FINAL ACTION E-MAILED
Thursday, May 2, 2019NON-FINAL ACTION WRITTEN
Thursday, April 25, 2019ASSIGNED TO EXAMINER
Friday, March 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 18, 2019NEW APPLICATION ENTERED

Related Keywords

biotherapeutics treatment development cancer prevention therapies research scientific namely information fields